HMOC, a chrysin derivative, induces tolerogenic properties in lipopolysaccharide-stimulated dendritic cells

Immunology and Microbiology

• Dendritic Cell 100%
• Regulatory T Cell 100%
• Bone Marrow Derived Dendritic Cell 100%
• T-Helper Cell 66%
• Tumor Necrosis Factor 33%
• Interleukin-1 33%
• Th17 Cell 33%
• Proinflammatory Cytokine 33%
• Antigen Presentation 33%
• Cytotoxic T-Cell 33%
• Indoleamine 2,3-dioxygenase 33%
• Interleukin 10 33%
• CD4 33%
• Atopic Dermatitis 33%
• Cell Differentiation 33%
• CD80 33%
• CD86 33%
• Th2 Cell 33%
• CD25 33%

Keyphrases

• Dendritic Cells 100%
• Lipopolysaccharide 100%
• Chrysin Derivatives 100%
• Tolerogenic 100%
• MHC Class II 36%
• Bone Marrow-derived Dendritic Cells 27%
• Treg 18%
• Anti-inflammatory Mechanism 18%
• Ionizing Radiation 9%
• Inflammatory Cytokines 9%
• Interleukin-1β 9%
• Antigen Presentation 9%
• Phenotypic Change 9%
• P38 Signaling Pathway 9%
• CD4+ T Cells 9%
• CD8+ T Cells 9%
• Indoleamine 2,3-dioxygenase 1 (IDO1) 9%
• Interleukin-10 9%
• CD4+ 9%
• CD86 9%
• JNK Pathway 9%
• Atopic Dermatitis 9%
• CD80 9%
• Functional Change 9%
• Surface Molecules 9%
• Th2 Cells 9%
• MHC Antigens 9%
• IL-12p70 9%
• T Helper 17 (Th17) 9%
• Th1-Th2 9%
• Therapeutic Candidates 9%
• Th Cell Differentiation 9%
• CD4+CD25+ Regulatory T Cells 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Lipopolysaccharide 100%
• Chrysin 100%
• Anti-Inflammatory Drug 18%
• Tumor Necrosis Factor 9%
• Cytokine 9%
• CD8 Antigen 9%
• Interleukin 10 9%
• Atopic Dermatitis 9%
• Indoleamine 2,3 Dioxygenase 9%
• Ionizing Radiation 9%